This content is machine translated Exercise and sport for Parkinson's disease Regular physical activity reduces mortality in Parkinson’s disease patients Parkinson’s patients often have muscle weakness, which is exacerbated by lack of exercise. This increases the risk of osteoporosis, falls and fractures. Physical activity and exercise can help improve walking…
View Post 7 min This content is machine translated Immunological and molecular biological aspects MALT type gastric lymphoma MALT lymphomas most commonly affect the stomach. Causally, there is a strong association with Helicobacter pylori (Hp) gastritis (over 90% of patients). With adequate antibiosis, Hp can be eradicated, leading…
View Post 4 min This content is machine translated Pain Congress in Hamburg Pain therapy – balancing efficacy and tolerability At the German Pain Congress in Hamburg, experts provided insights into the current options for pain therapy. This is not infrequently characterized by patients having to weigh up (especially gastrointestinal)…
View Post 9 min This content is machine translated Arrhythmias Pacemakers and devices – what’s new? Various studies have recently led to an expansion of indications for cardiac resynchronization therapy. The desire to avoid intravascular leads connected to a subcutaneous device has led to the development…
View Post 3 min This content is machine translated News from the ASH Congress on Nivolumab High response rates even in pretreated Hodgkin’s lymphomas Preclinical studies show that Sternberg-Reed cells, characteristic of classical Hodgkin lymphoma, use the PD-1 pathway to evade immunodetection. Therefore, immune checkpoint inhibitors such as nivolumab, which binds to the PD-1…
View Post 2 min This content is machine translated Season and thrust activity in MS More sun, fewer relapses Sun exposure and MS risk are linked – this is nothing new. But is the relapse rate of those who are already ill also influenced by the seasons? And are…
View Post 8 min This content is machine translated Rituximab, eculizumab, eprodisate New treatment options for glomerular diseases Glomerular diseases are important causes of end-stage renal failure. Pathogenetically, immune-mediated processes are in the foreground. Thanks to advancing knowledge of the pathophysiology and modern genetic engineering methods, there is…
View Post 2 min This content is machine translated Immunosuppression in prostate cancer New therapeutic targets are being explored What is certain: The survival prognosis of metastatic castration-resistant prostate cancer (mCRPC) has improved – on average from just over one (before 2000) to almost three years [1]. Nevertheless, current…
View Post 6 min This content is machine translated Not always bronchitis or asthma Cough in a child – how to clarify and treat? Cough in a child usually has a harmless cause, but can be very stressful for the patient and the whole family. If the cough occurs as the sole symptom, asthma…
View Post 4 min This content is machine translated 2014 Joint ACTRIMS-ECTRIMS Meeting Prizes for promising research in the field of multiple sclerosis At the 2014 Joint ACTRIMS-ECTRIMS Meeting in Boston (September 10-13, 2014), the GMSI Award (Grant for Multiple Sclerosis Innovation) was presented to the winners for the second time. The goal…
View Post 2 min This content is machine translated Bladder Cancer Promising immunotherapy A new phase I trial with a compound targeting the immunosuppressive protein PDL1 shows promising results with a good toxicity profile. This provides a potentially new class of drugs for…
